Journal article
Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges
With adequate education of all stakeholders, HPV vaccination is acceptable and feasible in Cameroon. Following this demonstration project, in 2014 the Global Access to Vaccines and Immunization (GAVI) Alliance awarded the Cameroon MOH HPV vaccine at a price of US$4.50 per dose to immunize sixth grade girls and girls aged 10 years who are not in school in two districts of Cameroon.
Authors
Languages
- English
Publication year
2014
Journal
Vaccine
Volume
35
Type
Journal article
Categories
- Service delivery
Diseases
- HPV
Countries
- Cameroon
Organisations
- Gavi, the Vaccine Alliance
Tags
- New vaccine introduction
- Performance monitoring
- Planning, budgeting and financing
WHO Regions
- African Region